A trial to classify cancer of unknown primary
Part of Cancer clinical trials.
This trial is for people whose cancer started in an unknown place (cancer of unknown primary). It uses a special test called PaCIFiC-CUP to help classify the cancer, which may guide better treatment choices.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a tumor sample that you gave permission to use for research.
- Your cancer was diagnosed as a primary site unknown tumor (the doctors don't know where it started).
- You have already received some kind of treatment for your cancer (like chemotherapy).
- Your doctors have your complete medical and lab records.
- You are able to get up and take care of yourself (ECOG score 0-2).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for people with cancer of unknown primary (CUP), meaning cancer that started in an unknown place in the body. It aims to use advanced genomic testing (looking at your tumor's DNA) on your stored tumor sample and blood to find clues about where the cancer began and possible treatment options.
This trial is for people with cancer of unknown primary — meaning the cancer has spread, but the original source can't be found. The study aims to better understand these cancers and find more personalized treatments by testing biopsy samples and giving tailored care.
This trial looks at the experiences of people with cancer of unknown primary (CUP) and their caregivers. It aims to understand what it's like to live without a clear diagnosis and how to improve support.
This trial tests a radioactive drug called Lu-177 FAP-2286 for people with cancer that started in an unknown place (CUP). It may help shrink tumors by targeting a protein found on many cancer cells.
This study looks at people with rare solid tumors or lymphoma to understand their cancer’s genetic changes. It collects blood and existing tissue samples (from standard care) for DNA testing and gathers health information to help improve knowledge about rare cancers.
This trial studies advanced solid tumors by using stored tumor samples to look for molecular clues. The goal is to help doctors better choose cancer treatments that may work for your specific tumor.
Hear when a new Unknown Primary Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.